Aadi Bioscience Inc AADI:NASDAQ

Last Price$20.51NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/06/21

Today's Change+1.19(6.16%)
Bid (Size)N/A (N/A)
Ask (Size)N/A (N/A)
Day Low / High$18.81 - 21.10
Volume215.1 K
 

Read more news Recent News

--HC Wainwright Adjusts Aadi Bioscience's Price Target to $49 From $47, Keeps Buy Rating
7:19AM ET 11/24/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Nudging Back Onto Positive Ground
4:02PM ET 11/23/2021 MT Newswires

Health care stocks were edging higher this afternoon, with the NYSE Health Care Index rising less than 0.1% while the SPDR Health Care Select Sector ETF...

Sector Update: Health Care Stocks Partially Recover From Morning Slide
1:51PM ET 11/23/2021 MT Newswires

Health care stocks were moderately lower this afternoon, with the NYSE Health Care Index falling 0.2% while the SPDR Health Care Select Sector ETF (XLV)...

Sector Update: Health Care
1:30PM ET 11/23/2021 MT Newswires

Health care stocks were moderately lower this afternoon, with the NYSE Health Care Index falling 0.2% while the SPDR Health Care Select Sector ETF (XLV)...

View all Commentary and Analysis

Aadi Bioscience: FDA Approval Of Fyarro Only The Beginning
2:33AM ET 11/25/2021 Seeking Alpha

Aerpio Pharmaceuticals: Is This Stock A Buy Or Sell? Not Until The Merger Is Over
1:45PM ET 7/30/2021 Seeking Alpha

Wall Street Breakfast: What Moved Markets
8:31AM ET 5/22/2021 Seeking Alpha

Company Profile

Business DescriptionAadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in October, 2011 and is headquartered in Los Angeles, CA. View company web site for more details
Address17383 Sunset Boulevard
Los Angeles, California 90272
Phone+1.513.985.1920
Number of Employees27
Recent SEC Filing11/29/20213
President, CEO, Secretary & DirectorNeil P. Desai
Chief Operating OfficerBrendan Delaney
Treasurer, Chief Financial & Accounting OfficerScott M. Giacobello
Chief Medical OfficerLoretta M. Itri

Company Highlights

Price Open$19.36
Previous Close$20.51
52 Week Range$14.31 - 49.80
Market Capitalization$428.5 M
Shares Outstanding20.9 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement03/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$7.77
Beta vs. S&P 500N/A
Revenue$20.2 M
Net Profit MarginN/A
Return on Equity-150.10%

Analyst Ratings as of 09/30/2021

Buy
4
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset